Sarepta plans regulatory submissions for two Duchenne drugs by April 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. ABBV
8. USO
9. MSFT
10. IBM

Go back to Sarepta plans regulatory submissions for two Duchenne drugs by April 2026
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.65 --0 (-0%)
Previous Close $17.65    52 Week High $63.73 
Open $17.65    52 Week Low $8.00 
Day High $17.65    P/E N/A 
Day Low $17.65    EPS $-5.69 
Volume 434